CSL CEO on Financial Results, Business Outlook
Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
Most Recent Videos
Was the DNC Hack Preventable?
48:29 - Eric O'Neill, Carbon Black's national security strategist, discusses how to respond to government hacks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)